4//SEC Filing
Longpre Lara 4
Accession 0001209191-23-030966
CIK 0001759425other
Filed
May 18, 8:00 PM ET
Accepted
May 19, 4:05 PM ET
Size
7.9 KB
Accession
0001209191-23-030966
Insider Transaction Report
Form 4
Longpre Lara
Chief Development Officer
Transactions
- Award
Common Stock
2023-05-10$16.92/sh+684$11,576→ 106,843 total
Footnotes (1)
- [F1]This Form 4 is being filed voluntarily to report the acquisition of 684 shares by the Reporting Person on May 10, 2023 pursuant to the Issuer's Employee Stock Purchase Plan.
Documents
Issuer
Mirum Pharmaceuticals, Inc.
CIK 0001759425
Entity typeother
Related Parties
1- filerCIK 0001780347
Filing Metadata
- Form type
- 4
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 4:05 PM ET
- Size
- 7.9 KB